Author

Xinchao Ban

Chinese Academy of Medical Sciences & Peking Union Medical College

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1 Assay:metagenomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Bing CuiiD· 1 shared Hongyu Yuan· 1 shared Jianli LiuiD· 1 shared Jiaojiao YuiD· 1 shared Jichao ZhouiD· 1 shared Jinmei YuiD· 1 shared Ning XuiD· 1 shared Pengyue Liu· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bing CuiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting Non-Catalytic Sites of SRC Sensitizes the Efficacy of SRC Kinase Inhibitors in Solid Tumors

Jinmei Yu, Xusheng Wang, Pengyue Liu, Zhenhe Wang, Jianli Liu, Qianwen Zhang, Zewen Zhang, Tian Gan, Ning Xu, Jichao Zhou, Jiaojiao Yu, Hongyu Yuan, Xinchao Ban, Pingping Li, Xiaowei Zhang, Bing Cui

This study identifies non-catalytic SRC functions as a mechanism of resistance to SRC kinase inhibitors and presents TS1-2 as a peptide that enhances inhibitor efficacy in solid tumors.

bioRxiv · Feb 15, 2025 · PreprintCancer Biology